Searchable abstracts of presentations at key conferences in endocrinology

ea0021p195 | Endocrine tumours and neoplasia | SFEBES2009

Ectopic Cushings complicated by paraneoplastic cerebral vasculopathy requiring high-dose steroid therapy

Jordan Alice , Parr John , Thomas Cecil , Wahid Shahid

In October 2006 a 53-year-old, non-smoking woman presented with ectopic Cushings from a small cell, undifferentiated carcinoma (Grade 3 neuroendocrine) from a 10 mm tumour at the left lung hilum (Cortisol: 09:00 a.m. 720 nmol/l; 24.00 mm 742 nmol/l. ACTH 114 ng/l). Four years before she had sustained a myocardial infarction, with atrial fibrillation, and was found to have Graves’ disease, being treated initially with carbimazole then radioactive iodine, becoming hypothyro...

ea0015p378 | Thyroid | SFEBES2008

Specificity of first-line tests for the diagnosis of Graves’ disease: assessment in a large series of hyperthyroid patients

Razvi Salman , Perros Petros , Parr John , Wahid Shahid

Context: Hyperthyroidism is a common endocrine condition that can be associated with significant morbidity. It is important to ascertain the underlying cause of hyperthyroidism as the natural history, potential complications and response to treatment can be very different.Objective: To investigate if measurement of TSH-receptor binding inhibitory immunoglobulin (TBII), a TSH-receptor antibody found in Graves disease, in the serum of newly diagnosed hyper...

ea0013p47 | Clinical practice/governance and case reports | SFEBES2007

Audit of testosterone replacement therapy at South Tyneside

Ibrahim Ibrahim M , Jordan Alice , Parr John , Wahid Shahid

Aims: Despite the plethora of testosterone therapies, Successful testosterone replacement remains a challenge. We assessed patient empowerment, treatment satisfaction and adherence to current testosterone replacement guidelines.Methods: Data were collected from case notes and a testosterone diary questionnaire in 16-patients with testosterone deficiency.Results: Median age was 46-years (range 21–69). All patients received an e...

ea0013p64 | Clinical practice/governance and case reports | SFEBES2007

Synacthen Tests – Do we overinvestigate?

Parr John , Scorer Gemma , Jordan Alice , Gillespie Susan , Wahid Shahid

The synacthen test is a commonly performed endocrine test; we have looked at whether we overuse this test. Of 150 synacthen tests performed in one year 52 were randomly selected for audit. 19 were undertaken for symptoms alone (Group 1); 16 for a low random cortisol (below 261 nmom/l – Group 2); 17 for electrolyte disturbances (either low sodium, high potassium or both – Group 3). 3 in Group 2 and 1 in Group 1 were abnormal but in no patient with a random cortisol ab...

ea0013p65 | Clinical practice/governance and case reports | SFEBES2007

Application of specific thyroid function test reference range in pregnancy

Parr John , Gillespie Susan , Jones Anthony , Wahid Shahid

Thyroid hormone and TSH levels change during pregnancy yet most laboratories use reference ranges derived from subjects who are not pregnant and male. Does this lead to an underestimation of thyroid disorders in pregnancy?We have derived our own reference range for Free T4 and TSH levels in pregnancy. The hormones were measured in 82 euthyroid mothers at booking and 68 at 28 weeks of pregnancy. Mean (95%CI: reference range of +2SD) FT4 levels were...

ea0013p311 | Thyroid | SFEBES2007

A case of Burkitt’s lymphoma of the thyroid presenting as myxoedema coma

Ibrahim Ibrahim M , parr John , Pritchet Christopher , Wahid Shahid

Introduction: Myxoedmea coma is an extreme expression of hypothyroidism with a high mortality rate. It is rarely associated with thyroid lymphoma.Case report: A 66-year-old lady presented acutely unwell with a two week history of cough and shortness of breath. She was hypothermic, hypoxic with clinical and radiological signs of pneumonia. Her TSH was 99.8 mU/L and T4 less than 5 pmol/L with strongly positive thyroid microsomal antibodies, raised WBC and ...

ea0077lb19 | Late Breaking | SFEBES2021

Post noradrenaline infusion induced gangrene of the toes

Ahmed Suhail , Ahmed Khan Shahid , Ajay Joshua , Dave Mika , Kumar Satish , Dashora Umesh Kumar

Noradrenaline (NE) is a peripheral vasoconstrictor reducing mortality by 11% and major adverse events by two-thirds compared to dopamine [1]. NE acts as an agonist at alpha1 and beta1 receptors, with little-to-no beta2 or alpha2 activity. This vasoconstriction effect can be potent and can result in completely occluded blood vessels more frequently in the peripheries due to lower blood pressure. Septic shock accounts for nearly 1 in 10 admissions to ICU, where it is the most co...

ea0077lb36 | Late Breaking | SFEBES2021

Small cell lung cancer presenting as hyperglycaemia and paraneoplastic syndrome

Ahmed Suhail , Khanna Alesha , Carter Alexander , Chua Aldons , Ahmed Khan Shahid , Kumar Satish , Dashora Umesh Kumar

• A 54-year old Lithuanian man presented with symptomatic hyperglycaemia and weight loss.• A diagnosis of new onset diabetes type 2 was confirmed for which he received treatment. In addition, his serum potassium remained low despite of intervention.• CXR was done and showed a bulky right sided hilar mass.• The combination of refractory hypokalaemia, hyperglycaemia, and lung cancer suspicio...

ea0011p133 | Clinical case reports | ECE2006

Giant labia majora in familial partial lipodystrophy

Kyaw Tun T , Correia N , Phelan NA , Shahid M , Buckley O , Prendeville W , Gibney J

Partial lipodystrophy syndromes are characterised by a selective paucity of subcutaneous adipose tissue on the trunk and limbs but excessive fat on the face, neck, supraclavicular areas and pelvis. Metabolic complications include insulin resistance and polycystic ovary syndrome (PCOS). There have been no previous reports of genital disfiguremment in these conditions.We present the case of a 27 years old female, who initially presented to the gynaecology ...

ea0011p503 | Endocrine tumours and neoplasia | ECE2006

Glucagonoma syndrome – treatment with intensive insulin and high dose vitamin B

Phelan NA , Shahid M , Correia N , Kyaw Tun T , Conlon KC , Gibney J

Malignant glucagonomas are slow-growing tumours which more commonly cause symptoms through glucagon hypersecretion than through effects of tumour bulk. The glucagonoma syndrome includes necrolytic migratory erythema (NME), diabetes mellitus, weight loss, anaemia, chelitis, venous thrombosis and neuropsychiatric symptoms. The syndrome probably results from unrestrained proteolysis1, and rapid consumption of B-vitamins through accelerated intermediate metabolism2...